Marco Investment Management LLC Repligen Corp Transaction History

Marco Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $240,162 - $295,335	-970 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$194.77 - $324.21 $48,692 - $81,052	-250 Reduced 20.49%	970 $280,000
Q2 2021 Aug 11, 2021	SELL	$165.87 - $220.95 $6,634 - $8,838	-40 Reduced 3.17%	1,220 $244,000
Q1 2021 May 06, 2021	SELL	$180.37 - $226.26 $36,074 - $45,252	-200 Reduced 13.7%	1,260 $245,000
Q4 2020 Feb 11, 2021	SELL	$148.08 - $206.57 $35,539 - $49,576	-240 Reduced 14.12%	1,460 $280,000

Q2 2020 Jul 21, 2020	SELL	$94.33 - $140.48 $35,373 - $52,679	-375 Reduced 18.07%	1,700 $210,000
Q1 2020 Apr 17, 2020	BUY	$84.96 - $109.14 $176,292 - $226,465	2,075 New	2,075 $200,000
Q3 2019 Nov 12, 2019	SELL	$76.65 - $95.51 $205,038 - $255,489	-2,675 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$54.2 - $85.95 $144,985 - $229,916	2,675 New	2,675 $230,000

522

53.2M

1.05M

228K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.67B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Marco Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Marco Investment Management LLC with notifications on news.